Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Manufacturing (cGMP) deviations

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards.

1,754 FDA drug recalls with this cause, newest first.

This category covers departures from current Good Manufacturing Practice during production. It is FDA's broadest label, used when a facility's own process control failed somewhere along the line even if no single ingredient was proven unsafe on its own. Where the report names a specific consequence - a temperature excursion, a contaminant, a potency problem - we file the recall under that more specific cause instead; what remains here is the genuinely general case.

Class II · Moderate risk

Nature-Throid 1 GR

CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.

Terminated cGMP deviation PD-Rx Pharmaceuticals, Inc. NDC 43063-819-01 D-0005-2021
Class II · Moderate risk

Genesis Hand Sanitizer Gel

CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.

Ongoing cGMP deviation Genesis Partnership Company SA NDC 74484-002-04 D-0039-2021
Class II · Moderate risk

Genesis Hand Sanitizer Gel

CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.

Ongoing cGMP deviation Genesis Partnership Company SA NDC 74484-002-02 D-0038-2021
Class II · Moderate risk

Panagel Hand Sanitizer

CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.

Ongoing cGMP deviation Genesis Partnership Company SA NDC 78384-001-04 D-0037-2021
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-7605-09 D-1624-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-7604-09 D-1623-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-6860-09 D-1622-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-9283-01 D-1621-2020
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Product contains acetaldehyde and acetal above the allowable limits.

Terminated cGMP deviation Charles Paint Research Inc D-0792-2021
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Product manufactured in same facility where product was found to contain acetaldehyde and acetal above the allowable limits.

Terminated cGMP deviation Charles Paint Research Inc D-0791-2021
Class II · Moderate risk

Cephalexin for Oral Suspension

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Terminated cGMP deviation Teva Pharmaceuticals USA NDC 0093-4177-73 D-0013-2021
Class II · Moderate risk

Cephalexin for Oral Suspension

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Terminated cGMP deviation Teva Pharmaceuticals USA NDC 0093-4175-73 D-0012-2021